ArticlePloS one2025
ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway.
Taipengfei Shu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticlePloS one2025
Taipengfei Shu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.